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E

strogens have profound effects on hippocampal structure
and physiology (1–4) and on hippocampal-dependent learning and memory (5, 6). In particular, estrogens have been shown
to increase the density of dendritic spines on CA1 pyramidal
neurons (7). In hippocampal slices, 17␤-estradiol increases electrophysiological responses elicited by activation of both ␣-amino3-hydroxy-5-methylisoxazole propionic acid and N-methyl-Daspartate (NMDA) receptors and the magnitude of long-term
potentiation (LTP) in field CA1 (8, 9). At the cellular level,
numerous laboratories have shown that, in addition to direct
genomic effects, 17␤-estradiol activates the extracellular regulated kinase兾mitogen-activated protein (ERK兾MAP) kinase
pathway (10–12), an effect associated with the neurotrophic兾
neuroprotective actions of estrogen (13, 14). We recently reported that estrogen-mediated activation of the ERK兾MAP
kinase pathway in hippocampus was involved in the rapid effects
of estrogen on NMDA receptors and LTP through tyrosine
phosphorylation of NR2 subunits of NMDA receptors (15).
The ERK兾MAP kinase pathway is a central cellular signaling
pathway linking numerous extracellular signals to membrane
receptors, transcription factors, and gene regulation (16) and is
critically involved in synaptic plasticity, learning, and memory
(17–20). Pharmacological manipulations directed at blocking
this pathway have consistently produced impairment in synaptic
plasticity, learning, and memory, and this pathway is activated
with LTP-inducing tetanus or in different learning paradigms.
The present study analyzed whether endogenous estrogen regulates the state of activation of the ERK兾MAP kinase pathway
and whether cyclic variations in estrogen levels during the female
estrus cycle suffice to modify this pathway in the brain. Moreover, we determined the state of tyrosine phosphorylation of
NMDA-receptor subunits, as well as the magnitude of LTP in
field CA1 of hippocampal slices obtained from adult female rats
with low (diestrus) or high (proestrus) endogenous estrogen
levels. Our results indicate that cyclic changes in female sexual
hormones are associated with marked variations in the state of
www.pnas.org兾cgi兾doi兾10.1073兾pnas.241507698

activation of a major cellular signaling pathway in the brain and
in a cellular model of learning and memory.
Materials and Methods
Ovariectomy. A total of 11 sexually naive, Sprague–Dawley
female rats (Harlan Breeders, Indianapolis) were used. Ovariectomy (OVX) was performed at 9 weeks, and 17␤-estradiol
(n ⫽ 5) or placebo (n ⫽ 6) implantation was done at 12 weeks.
Animals were killed by decapitation at 14 weeks; brains were
rapidly removed and kept at ⫺70°C until use. To verify the
efficacy of the procedures, uterine tissues were weighted at the
time of killing with the following results: OVX ⫹ 17␤-estradiol ⫽
0.35 ⫾ 0.03 g, OVX ⫹ placebo ⫽ 0.08 ⫾ 0.01 g. The 17␤-estradiol
60-day release pellets (0.72 mg per pellet) and placebo pellets
were purchased from Innovative Research of America.
Tissue Preparation and Western Blotting. Brain tissues were homog-

enized in 20% (wt兾vol) sucrose in PBS with 3.0 mM EGTA.
Aliquots of homogenates (30–40 g of protein per lane) were
diluted with equal volumes of 2⫻ sample buffer [2% SDS兾50
mM Tris䡠HCl, pH 6.8兾10% (vol兾vol) 2-mercaptoethanol兾10%
glycerol (vol兾vol)兾0.1% bromophenol blue]. After heating samples at 90- to 100°C for 5 min, proteins were subjected to
SDS兾PAGE (21) and transferred onto nitrocellulose membranes
(22). Anti-NR2 and anti-phosphotyrosine antibodies were obtained from Chemicon and Upstate Biotechnology (Lake Placid,
NY), respectively. Anti-p38 (activated兾diphosphorylated p38)
and anti-MAP kinase antibodies (nonphosphorylated ERK and
activated兾diphosphorylated ERK-1 and -2) were purchased
from Sigma. Immunoblots were scanned and the digitized images
were quantitatively analyzed by densitometry with the IMAGEQUANT program providing peak areas and apparent molecular
weights. For immunoprecipitation, samples were first centrifuged at 14,000 ⫻ g for 15–20 min. The supernatant was
discarded, the pellet resuspended in 100 M EGTA in distilled
water, and centrifuged again as above. The pellet was resuspended in Tris-acetate (100 mM, pH 7.4) containing 100 M
EGTA and centrifuged again. The supernatant was discarded,
and this last step was repeated at least once. The final pellet was
resuspended in the Tris-acetate buffer and frozen at ⫺70°C until
used. Membranes fractions (⬇ 300 g of protein) were lysed in
PBS containing protease inhibitors (0.1 mM PMSF兾1 g兾ml
pepstatin A兾1 g/ml leupeptin) and 2 mM EDTA. Membranes
then were sonicated and centrifuged at 4°C for 10 min at
100,000 ⫻ g. Membrane fractions were resuspended in lysis
buffer containing 1% SDS and heated at 95°C for 5 min, followed
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Hippocampal synaptic structure and function exhibit marked variations during the estrus cycle of female rats. Estradiol activates the
mitogen-activated protein (MAP) kinase pathway in numerous cell
types, and MAP kinase has been shown to play a critical role in the
mechanisms underlying synaptic plasticity. Here, we report that
endogenous estrogen produces a tonic phosphorylation兾activation of extracellular signal-regulated kinase 2 (ERK2)兾MAP kinase
throughout the female rat brain and an increase in tyrosine
phosphorylation of NR2 subunits of N-methyl-D-aspartate (NMDA)
receptors. Moreover, cyclic changes in estrogen levels during the
estrus cycle of female rats are associated with corresponding
changes in the levels of activation of ERK2, the state of tyrosine
phosphorylation of NR2 subunits of NMDA receptors, and the
magnitude of long-term potentiation in hippocampus. Thus, cyclic
changes in female sexual hormones result in marked variations in
the state of activation of a major cellular signaling pathway critical
for learning and memory and in a cellular model of learning and
memory.

by dilution in 4 volumes of cold lysis buffer containing 2%
(vol兾vol) Triton X-100. Insoluble materials were removed by
centrifugation at 100,000 ⫻ g for 10 min. Protein A-agarose
(Upstate Biotechnology)兾anti-NR2A兾B antibody mixtures (3 g
of each) were added to the supernatant and incubated with
gentle agitation overnight at 4°C. Immunoreactive complexes
were recovered by centrifugation at 14,000 ⫻ g for 5 sec. The
pellets were washed first with lysis buffer [containing 2%
(vol兾vol) Triton X-100] then with PBS. Proteins were finally
eluted in 2⫻ sample buffer and incubated at 95°C for 5 min.
Immunoprecipitated proteins were subjected to SDS兾8% PAGE
and to immunoblotting as above.
Estrus-Cycle Testing and Hippocampal Slice Preparation. Adult fe-

male Sprague–Dawley rats (Harlan Breeders) were monitored
by means of photomicrographs of vaginal smears obtained for at
least 10 consecutive days before experimentation. Brain tissues
from rats in either proestrus or diestrus were obtained on the
morning in which these conditions were first observed. Trunk
blood was collected and analyzed for hormonal content through
RIA. Serum-estrogen levels were significantly higher (P ⬍ 0.05)
in the proestrus group (mean ⫽ 52.6 pg兾ml) compared with the
diestrus group (mean ⫽ 31.9 pg兾ml).
Hippocampal slices (400 m thick) from rats in either
proestrus or diestrus were prepared on the morning in which
these conditions were first observed, and transferred to an
interface-recording chamber (31.5°C) where the slices were
perfused with oxygenated artificial cerebrospinal fluid, as described (9). Extracellular field-excitatory postsynaptic potential
recordings (fEPSPs) were obtained from the apical dendritic
layer of the CA1 region by using glass microelectrodes filled with
2 M NaCl. fEPSPs were recorded by applying single-test pulses
(0.05 Hz, 100 s) at voltage intensities sufficient to evoke 50%
of the maximal fEPSP. LTP was induced by a brief period of
high-frequency stimulation (hfs; five trains of 20 pulses at 100
Hz) after a total of 40 min of pre-hfs stimulation. Subsequent
fEPSPs were monitored for 30 min post-hfs induction at the
pre-hfs stimulation rate and intensity. Electrophysiological recordings were collected, digitized, and stored in a computer
using AXOBASIC software.
A separate group of animals was used for biochemical analysis
of MAP kinase activation and NMDA-receptor subunit phosphorylation, as described above.
Results
We first examined the state of phosphorylation of ERK兾MAP
kinases in whole brains of ovariectomized female rats with or
without estrogen implants. This experimental approach provides
for controlled states of low or high endogenous circulating
estrogen levels. The results were quite remarkable, as levels of
phosphorylated (active) ERK2 were lowered by more than 95%
by OVX without estrogen (E2) implants (Fig. 1A). Similar results
were obtained for different brain regions (hippocampus, hypothalamus, piriform and frontal cortex; data not shown). In
contrast, no difference was observed for total ERK兾MAP kinase
levels (phosphorylated plus unphosphorylated) under these
conditions.
As we previously found that estrogen treatment of hippocampal slices resulted in tyrosine phosphorylation of NR2 subunits
of NMDA receptors (15), we determined the state of tyrosine
phosphorylation of NR2 subunits in brain after OVX with or
without E2 implants. Brain extracts were first immunoblotted
with anti-phosphotyrosine or anti-NR2A兾B antibodies (Fig. 1 B
and C). In both cases, the antibodies recognized a band with an
apparent Mr of 170 kDa, corresponding to NR2 subunits of
NMDA receptors. Although no differences in the levels of NR2
subunits were found in the brains of ovariectomized females with
or without estrogen implants, E2 treatment increased the levels
13392 兩 www.pnas.org兾cgi兾doi兾10.1073兾pnas.241507698

Fig. 1. Effects of ovariectomy on ERK- and NR2-subunit tyrosine phosphorylation in female rat brains. Brain tissues from ovariectomized female rats
without (OVX) or with (E2) estrogen implants were homogenized in Trisacetate buffer (100 mM, pH 7.4) containing 0.1 mM EGTA and processed for
Western blotting. Aliquots of homogenates (50 – 60 g protein per lane) were
subjected to SDS兾10% PAGE. Proteins were transferred onto nitrocellulose
membranes. (A) Membranes were processed with monoclonal antibodies
against active兾phosphorylated ERK. (Upper) Representative blot. (Lower)
Blots were quantified, and results for ERK1 (hatched bars) and ERK2 (black
bars) were expressed as percentages of the values found in samples from
female rats with estrogen implants (means ⫾ SEM of 6 – 8 animals). *, P ⬍ 0.01.
(B) Membranes were processed with anti-phosphotyrosine antibodies that
stain a band with an apparent Mr of 170 kDa, corresponding to NR2 subunits
of NMDA receptors (Upper). (Lower) Blots were quantified and results were
expressed as percentages of the values found in samples from female rats with
estrogen implants (means ⫾ SEM of 6 – 8 animals). *, P ⬍ 0.05. (C) Membranes
were processed with anti-NR2A兾B antibodies (Upper). (Lower) Blots were
quantified, and results were expressed as percentages of the values found in
samples from female rats with estrogen implants (means ⫾ SEM of 6 – 8
animals). (D) Brain tissues were homogenized and NR2A兾B receptors were
immunoprecipitated with anti-NR2A兾B antibodies. Immunoprecipitated proteins were subjected to SDS兾PAGE, and Western blotting was performed with
anti-phosphotyrosine antibodies (0.5–2 g兾ml). The bands migrating at 170
kDa were quantified, and results were expressed as percentages of the values
found in samples from female rats with estrogen implants (means ⫾ SEM of
6 – 8 animals). *, P ⬍ 0.01.

of the phosphorylated 170-kDa band by 100%. To extend these
results, brain extracts first were immunoprecipitated with antiNR2 antibodies before estimating the amounts of tyrosine
phosphorylated NR2 subunits with Western blots stained with
anti-phosphotyrosine antibodies (Fig. 1D). Levels of tyrosine
phosphorylation of NR2 subunits of NMDA receptors were
100% higher in ovariectomized females receiving estrogen
implants.
Although the previous results strongly suggested that endogenous estrogen produces a tonic activation of the ERK兾MAP
kinase pathway, we determined the state of activation of this
pathway during the phases of the estrus cycle associated with low
(diestrus) and high (proestrus) levels of circulating estrogen.
Brain samples at proestrus exhibited a 3-fold increase in the state
of phosphorylation兾activation of ERK2 kinase with only small
changes in the state of phosphorylation of ERK1 kinase as
compared with diestrus (Fig. 2A–C). Moreover, overall levels of
either ERK1 or ERK2 were not different between the two states.
Interestingly, the state of phosphorylation of another kinase
Bi et al.

belonging to this family of kinases, p38, was decreased in
proestrus as compared with diestrus (Fig. 2D). We also compared the levels of tyrosine phosphorylation of NR2 subunits of
NMDA receptors between the two states (Fig. 2E). Levels of
tyrosine phosphorylation of NR2 subunits were increased by
50% at proestrus above diestrus.
After our observations that estrogen increased the magnitude
of LTP in field CA1 of hippocampal slices from male rats (9, 15),
it was of interest to evaluate the magnitude of LTP in slices from
females in proestrus or diestrus conditions (Fig. 3). Extracellular
fEPSPs were recorded in CA1 for 40 min before administering
Bi et al.

hfs to the Schaffer collateral pathway. Hfs was immediately
followed by posttetanic potentiation (PTP) that decayed to
reach a stable potentiation, which was recorded for 30 min. No
difference in the magnitude of PTP was observed between slices
prepared from females in proestrus as compared with diestrus.
On the other hand, a significant difference was observed in the
magnitude of LTP between the two groups, with slices prepared
from females in proestrus exhibiting greater LTP than slices
from females in diestrus (56 ⫾ 9% vs. 25 ⫾ 6%, means ⫾ SEM
of six experiments; P ⬍ 0.05).
Discussion
Our results clearly establish that endogenous estrogen is a major
regulator of the important intracellular signaling cascade consisting of ERK兾MAP kinase pathway throughout the brain.
First, ovariectomy, a procedure that reduces circulating estrogen
levels by more than 90%, resulted in an almost complete
elimination of the activated兾phosphorylated state of ERK2. This
effect was completely reversed by restoring normal levels of
estrogen with estrogen pellet implantation. Second, cyclic
changes in estrogen levels occurring during the estrus cycle in
female rats also were associated with changes in the state of
PNAS 兩 November 6, 2001 兩 vol. 98 兩 no. 23 兩 13393
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Fig. 2. Changes in ERK-, p38-, and NR2-subunit tyrosine phosphorylation in
brain of female rats in proestrus and diestrus. Brain tissues from female rats in
diestrus or proestrus were homogenized in Tris-acetate buffer (100 mM, pH
7.4) containing 0.1 mM EGTA and processed for Western blotting. (A) Membranes were processed with monoclonal antibodies against total (top half) or
phosphorylated ERK (bottom half). (B and C) Blots similar to those shown in A
were quantified, and results for ERK1 (hatched bars) and ERK2 (black bars)
were expressed as percentages of the values found in samples from females in
diestrus (means ⫾ SEM of 6 – 8 animals). *, P ⬍ 0.01. (B, total ERK; C, phosphoERK). (D) Membranes were processed with antibodies against activated兾
phosphorylated p38 (Upper). (Lower) blots were quantified, and results were
expressed as percentages of the values found in samples from females in
diestrus (means ⫾ SEM of 6 – 8 animals). *, P ⬍ 0.05. (E) Membranes were
processed with anti-phosphotyrosine antibodies (Upper) or anti-NR2A兾B antibodies (Lower). Blots were quantified, and results were expressed as percentages of the values found in samples from females in diestrus (means ⫾
SEM of 6 – 8 animals). *, P ⬍ 0.01.

Fig. 3. Changes in LTP in field CA1 of hippocampal slices from female rats in
proestrus and diestrus. Hippocampal slices from female rats in proestrus or
diestrus were prepared as described (9). fEPSP amplitude and slope values
were obtained for each slice and averaged across slices to produce one
average for before and after the train of hfs. fEPSP amplitudes and slopes were
normalized for the 10-min pre-hfs period for each slice. Separate ANOVAs and
planned two-tailed t tests for the pre-hfs and post-hfs periods were used to
evaluate the effects of estrus cycle on fEPSP slope and amplitude. (A) Representative waveforms from female rats in proestrus and diestrus for pre-hfs (1)
and post-hfs (2) periods. (B) Means ⫾ SEM of fEPSP slopes recorded in slices
from female rats in proestrus (black circles; n ⫽ 6) and diestrus (white circles;
n ⫽ 5).

activation兾phosphorylation of ERK2. This effect was relatively
specific for ERK2, as only minimal changes for ERK1 and a
decrease in p38 phosphorylation were observed. Changes in
activation兾phosphorylation of ERK2 were associated with parallel changes in the state of tyrosine phosphorylation of NR2
subunits of NMDA receptors. This result was not unexpected, as
it was shown previously that various tyrosine kinases, including
Src and MAP kinase, can phosphorylate NR2 subunits (15, 23).
Finally, changes in estrogen levels during the estrus cycle also
were associated with changes in the magnitude of LTP in field
CA1 of hippocampal slices. This finding fits well with our
previous results showing that estrogen, by activating the MAP
kinase pathway and by increasing the state of tyrosine phosphorylation of NR2 subunits of NMDA receptors, produced an
increase in the magnitude of LTP in hippocampal slices (15). It
is also consistent with reports indicating facilitation of LTP
induction by estrogen in ovariectomized female rats (24), increased LTP in the afternoon of proestrus of female rats (25),
and increased LTP magnitude in proestrus as compared with
diestrus in CA1 of adult female rats (26). Therefore, we propose
that circulating levels of estrogen regulate the phosphorylation兾
activation state of ERK2. In turn, this regulation results in the
tyrosine phosphorylation of NR2 subunits of NMDA receptors,
an effect known to increase NMDA-receptor function (27).
These changes in NMDA-receptor function would be well suited
to account for changes in the magnitude of LTP observed with
changes in circulating estrogen levels.
The MAP kinase pathway occupies a central place in the
regulation of synaptic plasticity (refs. 17 and 18; Fig. 4). Pharmacological manipulations directed at blocking this pathway
have consistently produced impairment in synaptic plasticity,
learning, and memory, and this pathway is activated with LTPinducing tetanus or in different learning paradigms (28–31). Our
results indicate that circulating estrogen produces a tonic activation of this pathway throughout the brain. This effect could
therefore account for the various effects of estrogen on synaptic
plasticity reported in various brain structures. In particular,
activation of the MAP kinase pathway by estrogen could well be
responsible for the effects of estrogen on NMDA receptormediated responses and on synaptic connectivity in field CA1 of
hippocampus (4, 5).
Estrogen affects hippocampal-dependent learning and memory (5, 32). It has beneficial effects on working memory in
humans (33) and in spatial memory (34) or delayed matchingto-place (35) in rats. Our results not only provide a cellular
explanation for these effects but also indicate that fluctuations
in endogenous levels of estrogen have profound influences on
mechanisms that play central roles in these processes. Studies
related to changes in learning and memory processes during the
estrus cycle in females have provided variable results. In hippocampal-dependent tasks, Warren and Juraska (36) found
worse learning in proestrus, Berry et al. (37) reported no
difference for various phases of the cycle, whereas Frick and
Berger-Sweeney (38) reported increased learning performance
in proestrus. Interestingly, in a hippocampal-independent task,
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Fig. 4. Schematic representation of the cellular effects of estrogen in the
brain. Estrogen produces both the regulation of genomic events through its
binding to traditional hormonal receptors, the translocation of the estrogenreceptor complexes to the nucleus, and the activation of a major intracellular
cascade. The former pathway is expected to account for the slow effects of
estrogen on cells and tissues, including its neuroprotective兾neurotrophic
effects via the activation of antiapoptotic genes. In addition, estrogen activates the intracellular cascade consisting of the ERK兾MAP kinase pathway.
This pathway is well suited to regulate both additional genomic events after
translocation of activated ERK into the nucleus and also membrane receptors
[such as the ␣-amino-3-hydroxy-5-methylisoxazole propionic acid (AMPA) or
NMDA receptors], ion channels, and intracellular enzymes. This pathway is
expected to account for the rapid effects of estrogen on cells and tissues. In
particular, we postulate that tyrosine phosphorylation of NMDA receptors
results in the increased function of the receptors and facilitation of LTP
formation. This pathway also could be involved in the synaptic remodeling
taking place in hippocampus and other brain structures during the estrus
cycle.

Shors et al. (39) found substantially enhanced learning performance in proestrus. Inconsistent findings have been reported in
humans (40, 41). In any event, our results raise some challenging
questions regarding the functional significance of linking cellular
processes critical for cognitive processes with signals critical for
reproductive functions.
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